| Erlotinib |
ENSG00000118412.8 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Erlotinib |
ENSG00000181798.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Erlotinib |
ENSG00000182873.4 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Erlotinib |
ENSG00000204792.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Erlotinib |
ENSG00000214347.5 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Erlotinib |
ENSG00000214725.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Erlotinib |
ENSG00000214803.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Erlotinib |
ENSG00000219665.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Erlotinib |
ENSG00000223466.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Erlotinib |
ENSG00000223478.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Erlotinib |
ENSG00000223579.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Erlotinib |
ENSG00000223652.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Erlotinib |
ENSG00000223799.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Erlotinib |
ENSG00000223960.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Erlotinib |
ENSG00000224020.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Erlotinib |
ENSG00000224074.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Erlotinib |
ENSG00000224424.7 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Erlotinib |
ENSG00000224614.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Erlotinib |
ENSG00000224844.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Erlotinib |
ENSG00000224846.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Erlotinib |
ENSG00000225113.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Erlotinib |
ENSG00000225173.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Erlotinib |
ENSG00000225213.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Erlotinib |
ENSG00000225361.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Erlotinib |
ENSG00000225442.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Erlotinib |
ENSG00000225511.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Erlotinib |
ENSG00000225760.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Erlotinib |
ENSG00000225761.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Erlotinib |
ENSG00000226044.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Erlotinib |
ENSG00000226200.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Erlotinib |
ENSG00000226237.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Erlotinib |
ENSG00000226386.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Erlotinib |
ENSG00000226465.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Erlotinib |
ENSG00000226674.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Erlotinib |
ENSG00000226752.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Erlotinib |
ENSG00000226756.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Erlotinib |
ENSG00000226816.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Erlotinib |
ENSG00000226864.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Erlotinib |
ENSG00000227083.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Erlotinib |
ENSG00000227083.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Erlotinib |
ENSG00000227136.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Erlotinib |
ENSG00000227186.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Erlotinib |
ENSG00000227308.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Erlotinib |
ENSG00000227388.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Erlotinib |
ENSG00000228340.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Erlotinib |
ENSG00000228353.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Erlotinib |
ENSG00000228389.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Erlotinib |
ENSG00000228427.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Erlotinib |
ENSG00000228444.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Erlotinib |
ENSG00000229915.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Erlotinib |
ENSG00000229951.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Erlotinib |
ENSG00000230310.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Erlotinib |
ENSG00000230606.6 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Erlotinib |
ENSG00000230925.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Erlotinib |
ENSG00000231193.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Erlotinib |
ENSG00000231401.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Erlotinib |
ENSG00000231473.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Erlotinib |
ENSG00000231595.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Erlotinib |
ENSG00000231628.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Erlotinib |
ENSG00000231709.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Erlotinib |
ENSG00000231758.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Erlotinib |
ENSG00000231903.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Erlotinib |
ENSG00000232300.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Erlotinib |
ENSG00000232406.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Erlotinib |
ENSG00000232518.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Erlotinib |
ENSG00000232586.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Erlotinib |
ENSG00000232725.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Erlotinib |
ENSG00000232814.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Erlotinib |
ENSG00000232855.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Erlotinib |
ENSG00000232931.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Erlotinib |
ENSG00000233108.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Erlotinib |
ENSG00000233330.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Erlotinib |
ENSG00000233627.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Erlotinib |
ENSG00000233806.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Erlotinib |
ENSG00000233844.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Erlotinib |
ENSG00000233937.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Erlotinib |
ENSG00000234160.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Erlotinib |
ENSG00000234432.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Erlotinib |
ENSG00000234509.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Erlotinib |
ENSG00000234699.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Erlotinib |
ENSG00000234913.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Erlotinib |
ENSG00000234945.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Erlotinib |
ENSG00000235142.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Erlotinib |
ENSG00000236022.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Erlotinib |
ENSG00000236051.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Erlotinib |
ENSG00000236088.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Erlotinib |
ENSG00000236308.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Erlotinib |
ENSG00000236434.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Erlotinib |
ENSG00000236449.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Erlotinib |
ENSG00000236643.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Erlotinib |
ENSG00000237149.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Erlotinib |
ENSG00000237149.4 |
Predicted lncRNA |
Esophageal cancer |
|
| Erlotinib |
ENSG00000237356.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Erlotinib |
ENSG00000237424.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Erlotinib |
ENSG00000237424.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Erlotinib |
ENSG00000237438.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Erlotinib |
ENSG00000237781.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Erlotinib |
ENSG00000237940.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Erlotinib |
ENSG00000237989.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Erlotinib |
ENSG00000239002.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Erlotinib |
ENSG00000239407.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Erlotinib |
ENSG00000239552.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Erlotinib |
ENSG00000240207.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Erlotinib |
ENSG00000240758.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Erlotinib |
ENSG00000240770.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Erlotinib |
ENSG00000241211.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Erlotinib |
ENSG00000241269.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Erlotinib |
ENSG00000241481.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Erlotinib |
ENSG00000241770.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Erlotinib |
ENSG00000242042.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Erlotinib |
ENSG00000242086.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Erlotinib |
ENSG00000242553.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Erlotinib |
ENSG00000242861.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Erlotinib |
ENSG00000244380.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Erlotinib |
ENSG00000245275.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Erlotinib |
ENSG00000245281.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Erlotinib |
ENSG00000245667.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Erlotinib |
ENSG00000246331.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Erlotinib |
ENSG00000246695.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Erlotinib |
ENSG00000246889.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Erlotinib |
ENSG00000247134.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Erlotinib |
ENSG00000248399.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Erlotinib |
ENSG00000248599.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Erlotinib |
ENSG00000248677.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Erlotinib |
ENSG00000248773.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Erlotinib |
ENSG00000248936.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Erlotinib |
ENSG00000248936.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Erlotinib |
ENSG00000248996.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Erlotinib |
ENSG00000249084.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Erlotinib |
ENSG00000249084.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Erlotinib |
ENSG00000249359.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Erlotinib |
ENSG00000249593.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Erlotinib |
ENSG00000250057.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Erlotinib |
ENSG00000251023.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Erlotinib |
ENSG00000251221.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Erlotinib |
ENSG00000251602.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Erlotinib |
ENSG00000253476.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Erlotinib |
ENSG00000253563.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Erlotinib |
ENSG00000253567.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Erlotinib |
ENSG00000253688.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Erlotinib |
ENSG00000253829.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Erlotinib |
ENSG00000254154.4 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Erlotinib |
ENSG00000254226.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Erlotinib |
ENSG00000254295.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Erlotinib |
ENSG00000254315.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Erlotinib |
ENSG00000254682.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Erlotinib |
ENSG00000254694.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Erlotinib |
ENSG00000254929.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Erlotinib |
ENSG00000254968.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Erlotinib |
ENSG00000255276.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Erlotinib |
ENSG00000255348.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Erlotinib |
ENSG00000255409.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Erlotinib |
ENSG00000255651.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Erlotinib |
ENSG00000256116.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Erlotinib |
ENSG00000256576.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Erlotinib |
ENSG00000256588.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Erlotinib |
ENSG00000256747.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Erlotinib |
ENSG00000256940.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Erlotinib |
ENSG00000257167.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Erlotinib |
ENSG00000257264.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Erlotinib |
ENSG00000257499.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Erlotinib |
ENSG00000257563.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Erlotinib |
ENSG00000257890.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Erlotinib |
ENSG00000258082.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Erlotinib |
ENSG00000258096.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Erlotinib |
ENSG00000258172.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Erlotinib |
ENSG00000258268.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Erlotinib |
ENSG00000258317.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Erlotinib |
ENSG00000258317.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Erlotinib |
ENSG00000258334.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Erlotinib |
ENSG00000258378.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Erlotinib |
ENSG00000258486.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Erlotinib |
ENSG00000258646.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Erlotinib |
ENSG00000258733.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Erlotinib |
ENSG00000258920.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Erlotinib |
ENSG00000259201.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Erlotinib |
ENSG00000259515.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Erlotinib |
ENSG00000259520.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Erlotinib |
ENSG00000259579.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Erlotinib |
ENSG00000259672.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Erlotinib |
ENSG00000259802.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Erlotinib |
ENSG00000259974.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Erlotinib |
ENSG00000260137.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Erlotinib |
ENSG00000260188.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Erlotinib |
ENSG00000260213.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Erlotinib |
ENSG00000260261.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Erlotinib |
ENSG00000260317.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Erlotinib |
ENSG00000260425.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Erlotinib |
ENSG00000260439.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Erlotinib |
ENSG00000260774.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Erlotinib |
ENSG00000260804.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Erlotinib |
ENSG00000260898.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Erlotinib |
ENSG00000261019.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Erlotinib |
ENSG00000261096.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Erlotinib |
ENSG00000261126.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Erlotinib |
ENSG00000261342.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Erlotinib |
ENSG00000261433.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Erlotinib |
ENSG00000261783.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Erlotinib |
ENSG00000261799.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Erlotinib |
ENSG00000262194.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Erlotinib |
ENSG00000262228.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Erlotinib |
ENSG00000263727.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Erlotinib |
ENSG00000263931.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Erlotinib |
ENSG00000264043.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Erlotinib |
ENSG00000264853.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Erlotinib |
ENSG00000265148.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Erlotinib |
ENSG00000265443.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Erlotinib |
ENSG00000265478.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Erlotinib |
ENSG00000266411.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Erlotinib |
ENSG00000266456.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Erlotinib |
ENSG00000266717.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Erlotinib |
ENSG00000266801.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Erlotinib |
ENSG00000266900.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Erlotinib |
ENSG00000266901.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Erlotinib |
ENSG00000266975.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Erlotinib |
ENSG00000267004.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Erlotinib |
ENSG00000267042.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Erlotinib |
ENSG00000267161.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Erlotinib |
ENSG00000267219.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Erlotinib |
ENSG00000267249.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Erlotinib |
ENSG00000267278.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Erlotinib |
ENSG00000267298.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Erlotinib |
ENSG00000267457.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Erlotinib |
ENSG00000267481.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Erlotinib |
ENSG00000267543.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Erlotinib |
ENSG00000267745.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Erlotinib |
ENSG00000267759.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Erlotinib |
ENSG00000267798.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Erlotinib |
ENSG00000267940.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Erlotinib |
ENSG00000268266.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Erlotinib |
ENSG00000268316.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Erlotinib |
ENSG00000268366.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Erlotinib |
ENSG00000268530.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Erlotinib |
ENSG00000268912.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Erlotinib |
ENSG00000269191.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Erlotinib |
ENSG00000269321.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Erlotinib |
ENSG00000269423.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Erlotinib |
ENSG00000269574.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Erlotinib |
ENSG00000269906.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Erlotinib |
ENSG00000269925.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Erlotinib |
ENSG00000269949.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Erlotinib |
ENSG00000269997.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Erlotinib |
ENSG00000270061.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Erlotinib |
ENSG00000270066.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Erlotinib |
ENSG00000270091.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Erlotinib |
ENSG00000270130.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Erlotinib |
ENSG00000270140.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Erlotinib |
ENSG00000270143.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Erlotinib |
ENSG00000270159.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Erlotinib |
ENSG00000270174.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Erlotinib |
ENSG00000270562.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Erlotinib |
ENSG00000271020.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Erlotinib |
ENSG00000271204.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Erlotinib |
ENSG00000271228.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Erlotinib |
ENSG00000271382.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Erlotinib |
ENSG00000271553.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Erlotinib |
ENSG00000271751.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Erlotinib |
ENSG00000271778.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Erlotinib |
ENSG00000271803.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Erlotinib |
ENSG00000271840.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Erlotinib |
ENSG00000271857.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Erlotinib |
ENSG00000272029.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Erlotinib |
ENSG00000272077.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Erlotinib |
ENSG00000272233.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Erlotinib |
ENSG00000272308.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Erlotinib |
ENSG00000272308.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Erlotinib |
ENSG00000272377.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Erlotinib |
ENSG00000272430.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Erlotinib |
ENSG00000272518.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Erlotinib |
ENSG00000272520.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Erlotinib |
ENSG00000272644.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Erlotinib |
ENSG00000272672.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Erlotinib |
ENSG00000272707.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Erlotinib |
ENSG00000272744.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Erlotinib |
ENSG00000272760.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Erlotinib |
ENSG00000272761.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Erlotinib |
ENSG00000272792.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Erlotinib |
ENSG00000272834.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Erlotinib |
ENSG00000272861.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Erlotinib |
ENSG00000272953.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Erlotinib |
ENSG00000272960.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Erlotinib |
ENSG00000273084.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Erlotinib |
ENSG00000273165.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Erlotinib |
ENSG00000273185.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Erlotinib |
ENSG00000273240.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Erlotinib |
ENSG00000273281.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Erlotinib |
ENSG00000273319.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Erlotinib |
ENSG00000273366.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Erlotinib |
ENSG00000273443.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Erlotinib |
ENSG00000273473.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Erlotinib |
ENSG00000273493.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Erlotinib |
hsa-let-7d-5p |
predicted miRNA |
NCI60 |
|
| Erlotinib |
hsa-miR-101-3p |
predicted miRNA |
NCI60 |
|
| Erlotinib |
hsa-miR-106a-5p |
predicted miRNA |
NCI60 |
|
| Erlotinib |
hsa-miR-106b-5p |
predicted miRNA |
NCI60 |
|
| Erlotinib |
hsa-miR-130b-3p |
predicted miRNA |
NCI60 |
|
| Erlotinib |
hsa-miR-132-3p |
predicted miRNA |
NCI60 |
|
| Erlotinib |
hsa-miR-183-5p |
predicted miRNA |
NCI60 |
|
| Erlotinib |
hsa-miR-185-5p |
predicted miRNA |
NCI60 |
|
| Erlotinib |
hsa-miR-18a-5p |
predicted miRNA |
NCI60 |
|
| Erlotinib |
hsa-miR-18b-5p |
predicted miRNA |
NCI60 |
|
| Erlotinib |
hsa-miR-204-5p |
predicted miRNA |
NCI60 |
|
| Erlotinib |
hsa-miR-211-5p |
predicted miRNA |
NCI60 |
|
| Erlotinib |
hsa-miR-22-3p |
predicted miRNA |
NCI60 |
|
| Erlotinib |
hsa-miR-23a-3p |
predicted miRNA |
NCI60 |
|
| Erlotinib |
hsa-miR-25-3p |
predicted miRNA |
NCI60 |
|
| Erlotinib |
hsa-miR-26a-5p |
predicted miRNA |
NCI60 |
|
| Erlotinib |
hsa-miR-27a-3p |
predicted miRNA |
NCI60 |
|
| Erlotinib |
hsa-miR-296-5p |
predicted miRNA |
NCI60 |
|
| Erlotinib |
hsa-miR-301b |
predicted miRNA |
NCI60 |
|
| Erlotinib |
hsa-miR-30b-5p |
predicted miRNA |
NCI60 |
|
| Erlotinib |
hsa-miR-30d-5p |
predicted miRNA |
NCI60 |
|
| Erlotinib |
hsa-miR-324-5p |
predicted miRNA |
NCI60 |
|
| Erlotinib |
hsa-miR-326 |
predicted miRNA |
NCI60 |
|
| Erlotinib |
hsa-miR-328 |
predicted miRNA |
NCI60 |
|
| Erlotinib |
hsa-miR-339-5p |
predicted miRNA |
NCI60 |
|
| Erlotinib |
hsa-miR-33b-5p |
predicted miRNA |
NCI60 |
|
| Erlotinib |
hsa-miR-340-5p |
predicted miRNA |
NCI60 |
|
| Erlotinib |
hsa-miR-342-3p |
predicted miRNA |
NCI60 |
|
| Erlotinib |
hsa-miR-345-5p |
predicted miRNA |
NCI60 |
|
| Erlotinib |
hsa-miR-362-3p |
predicted miRNA |
NCI60 |
|
| Erlotinib |
hsa-miR-365a-3p |
predicted miRNA |
NCI60 |
|
| Erlotinib |
hsa-miR-365b-3p |
predicted miRNA |
NCI60 |
|
| Erlotinib |
hsa-miR-374a-5p |
predicted miRNA |
NCI60 |
|
| Erlotinib |
hsa-miR-374b-5p |
predicted miRNA |
NCI60 |
|
| Erlotinib |
hsa-miR-378a-3p |
predicted miRNA |
NCI60 |
|
| Erlotinib |
hsa-miR-421 |
predicted miRNA |
NCI60 |
|
| Erlotinib |
hsa-miR-425-5p |
predicted miRNA |
NCI60 |
|
| Erlotinib |
hsa-miR-501-5p |
predicted miRNA |
NCI60 |
|
| Erlotinib |
hsa-miR-502-5p |
predicted miRNA |
NCI60 |
|
| Erlotinib |
hsa-miR-505-3p |
predicted miRNA |
NCI60 |
|
| Erlotinib |
hsa-miR-506-3p |
predicted miRNA |
NCI60 |
|
| Erlotinib |
hsa-miR-508-3p |
predicted miRNA |
NCI60 |
|
| Erlotinib |
hsa-miR-518a-5p |
predicted miRNA |
NCI60 |
|
| Erlotinib |
hsa-miR-532-5p |
predicted miRNA |
NCI60 |
|
| Erlotinib |
hsa-miR-545-3p |
predicted miRNA |
NCI60 |
|
| Erlotinib |
hsa-miR-550a-5p |
predicted miRNA |
NCI60 |
|
| Erlotinib |
hsa-miR-557 |
predicted miRNA |
NCI60 |
|
| Erlotinib |
hsa-miR-590-5p |
predicted miRNA |
NCI60 |
|
| Erlotinib |
hsa-miR-615-5p |
predicted miRNA |
NCI60 |
|
| Erlotinib |
hsa-miR-624-5p |
predicted miRNA |
NCI60 |
|
| Erlotinib |
hsa-miR-652-3p |
predicted miRNA |
NCI60 |
|
| Erlotinib |
hsa-miR-660-5p |
predicted miRNA |
NCI60 |
|
| Erlotinib |
hsa-miR-744-5p |
predicted miRNA |
NCI60 |
|
| Erlotinib |
hsa-miR-766-3p |
predicted miRNA |
NCI60 |
|
| Erlotinib |
hsa-miR-769-5p |
predicted miRNA |
NCI60 |
|
| Erlotinib |
hsa-miR-887 |
predicted miRNA |
NCI60 |
|
| Erlotinib |
hsa-miR-9-5p |
predicted miRNA |
NCI60 |
|
| Erlotinib |
hsa-miR-92b-3p |
predicted miRNA |
NCI60 |
|
| Erlotinib |
hsa-miR-93-5p |
predicted miRNA |
NCI60 |
|
| Erlotinib |
let-7c |
Curated miRNA |
non-small cell lung cancer |
|
| Erlotinib |
miR-135b |
Curated miRNA |
epithelial cancer(Non-small cell lung carcinoma (NSCLC) and pancreatic ductal adenocarcinoma (PDAC)) |
|
| Erlotinib |
miR-135b |
Curated miRNA |
pancreatic adenocarcinoma |
|
| Erlotinib |
miR-139 |
Curated miRNA |
pancreatic adenocarcinoma |
|
| Erlotinib |
miR-140 |
Curated miRNA |
epithelial cancer(Non-small cell lung carcinoma (NSCLC) and pancreatic ductal adenocarcinoma (PDAC)) |
|
| Erlotinib |
miR-141 |
Curated miRNA |
epithelial cancer(Non-small cell lung carcinoma (NSCLC) and pancreatic ductal adenocarcinoma (PDAC)) |
|
| Erlotinib |
miR-141 |
Curated miRNA |
pancreatic adenocarcinoma |
|
| Erlotinib |
miR-146a |
Curated miRNA |
non-small cell lung cancer |
|
| Erlotinib |
miR-155 |
Curated miRNA |
pancreatic adenocarcinoma |
|
| Erlotinib |
miR-197 |
Curated miRNA |
epithelial cancer(Non-small cell lung carcinoma (NSCLC) and pancreatic ductal adenocarcinoma (PDAC)) |
|
| Erlotinib |
miR-200 |
Curated miRNA |
cancer |
|
| Erlotinib |
miR-200a |
Curated miRNA |
pancreatic adenocarcinoma |
|
| Erlotinib |
miR-200b |
Curated miRNA |
epithelial cancer(Non-small cell lung carcinoma (NSCLC) and pancreatic ductal adenocarcinoma (PDAC)) |
|
| Erlotinib |
miR-200b |
Curated miRNA |
non-small cell lung cancer |
|
| Erlotinib |
miR-200b |
Curated miRNA |
pancreatic adenocarcinoma |
|
| Erlotinib |
miR-200c |
Curated miRNA |
epithelial cancer(Non-small cell lung carcinoma (NSCLC) and pancreatic ductal adenocarcinoma (PDAC)) |
|
| Erlotinib |
miR-200c |
Curated miRNA |
non-small cell lung cancer |
|
| Erlotinib |
miR-200c |
Curated miRNA |
pancreatic adenocarcinoma |
|
| Erlotinib |
miR-205 |
Curated miRNA |
epithelial cancer(Non-small cell lung carcinoma (NSCLC) and pancreatic ductal adenocarcinoma (PDAC)) |
|
| Erlotinib |
miR-205 |
Curated miRNA |
melanoma |
|
| Erlotinib |
miR-21 |
Curated miRNA |
non-small cell lung cancer |
|
| Erlotinib |
miR-224 |
Curated miRNA |
epithelial cancer(Non-small cell lung carcinoma (NSCLC) and pancreatic ductal adenocarcinoma (PDAC)) |
|
| Erlotinib |
miR-301a |
Curated miRNA |
epithelial cancer(Non-small cell lung carcinoma (NSCLC) and pancreatic ductal adenocarcinoma (PDAC)) |
|
| Erlotinib |
miR-30b |
Curated miRNA |
non-small cell lung cancer |
|
| Erlotinib |
miR-34a |
Curated miRNA |
head and neck cancer |
|
| Erlotinib |
miR-34a |
Curated miRNA |
non-small cell lung cancer |
|
| Erlotinib |
miR-34c |
Curated miRNA |
epithelial cancer(Non-small cell lung carcinoma (NSCLC) and pancreatic ductal adenocarcinoma (PDAC)) |
|
| Erlotinib |
miR-429 |
Curated miRNA |
pancreatic adenocarcinoma |
|
| Erlotinib |
miR-497 |
Curated miRNA |
pancreatic cancer |
|
| Erlotinib |
miR-518f* |
Curated miRNA |
epithelial cancer(Non-small cell lung carcinoma (NSCLC) and pancreatic ductal adenocarcinoma (PDAC)) |
|
| Erlotinib |
miR-628 |
Curated miRNA |
epithelial cancer(Non-small cell lung carcinoma (NSCLC) and pancreatic ductal adenocarcinoma (PDAC)) |
|
| Erlotinib |
miR-636 |
Curated miRNA |
epithelial cancer(Non-small cell lung carcinoma (NSCLC) and pancreatic ductal adenocarcinoma (PDAC)) |
|
